As part of an effort to design human renin inhibitors with improved bioavailability, the amino-terminal Phe-His element present in many classes of renin inhibitors was replaced by a sulfone containing isostere.
As part of an effort to design human renin inhibitors with improved bioavailability, the amino-terminal Phe-His element present in many classes of renin inhibitors was replaced by a sulfone containing isostere.